Spruce Biosciences Inc. (SPRB) Social Stream
Spruce Biosciences Inc (SPRB) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Spruce Biosciences Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 17 months, SPRB's average price target has gone down $23.95.
Over the past 50 weeks, SPRB's average upside potential has been 307.5%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
SPRB Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 59 days, SPRB's average broker recommendation rating improved by 0.13.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, Spruce Biosciences Inc's upside potential (average analyst target price relative to current price) is higher than 1154.77% of them.
- In the context of all US stocks, Spruce Biosciences Inc's variance in analysts' estimates is lower than -973.12% of them.
- In the context of stocks in the small market cap category, Spruce Biosciences Inc's average analyst price target is greater than 410.84% of them.
- SPRB has a higher number of analysts covering the stock than 342.75% of Healthcare stocks.
Is SPRB a Buy, Hold or Sell? See the POWR Ratings now!